Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What otc drugs interact with cosentyx?

See the DrugPatentWatch profile for cosentyx

How can OTC drugs interact with Cosentyx (secukinumab)?

Cosentyx (secukinumab) is a biologic monoclonal antibody that targets interleukin-17A. Because it isn’t broken down by common liver enzymes (like many small-molecule drugs), it generally has fewer classic “drug-drug interaction” risks than typical OTC medications. The main practical issues are instead: infection risk, immune effects, and which OTC products contain ingredients that overlap with a clinician’s concerns (for example, NSAIDs or supplements that can affect bleeding).

Which common OTC categories are most likely to matter?

OTC products that can matter for people taking Cosentyx tend to fall into these categories:

OTC pain relievers and fever reducers

  • Acetaminophen (Tylenol) is usually the first choice for pain/fever and typically doesn’t raise interaction concerns with Cosentyx.
  • NSAIDs (ibuprofen/Advil, naproxen/Aleve, aspirin) generally do not have a direct interaction with Cosentyx, but they can be relevant if you also have conditions that NSAIDs worsen (ulcers/bleeding risk, kidney disease, uncontrolled hypertension) or if a clinician is managing other medicines alongside Cosentyx.

Cold/flu and “immune support” products

OTC cold meds usually don’t interact directly with Cosentyx. The bigger issue is that some cold/flu products can:
- mask symptoms of an infection that should be evaluated, and
- include multiple active ingredients (which can be risky if you accidentally double-dose with another product).

Supplements marketed for inflammation/immune function

Some supplements can affect bleeding, blood pressure, or immune function. There’s no single “standard” supplement list that definitively interacts with Cosentyx, but supplements often warrant extra caution because evidence for safety in people on biologics is uneven.

Topicals and OTC creams

Most topical OTC products (antifungals, moisturizers, mild steroid creams) don’t have systemic interaction concerns with Cosentyx. The key caution is skin infections: if an OTC product is used to treat a possible infection, you may need a clinician’s guidance while on immunomodulatory therapy.

What about vaccines and OTC “immunity” products?

Cosentyx affects immune signaling, so vaccine choice is more important than OTC medicine interactions:
- Avoid live vaccines unless your clinician specifically clears them.
- Many common OTC cold/flu “immunity” approaches are not vaccines, but they also can delay care if you’re actually developing an infection.

What should patients do if they want to take a specific OTC product?

The safest approach is to check:
1. All active ingredients (including in combo products like cold/flu formulations).
2. Your other meds and health conditions (ulcers, kidney disease, anticoagulants, blood pressure issues).
3. Whether symptoms could be an infection (fever, worsening cough, painful red skin, etc.). If you’re sick, contact your clinician rather than self-treating only with OTC drugs.

If you tell me the exact OTC products, I can be specific

“OTC drugs” can mean many different formulations. If you share the brand name(s) or the active ingredients on the label (for example: ibuprofen + pseudoephedrine + dextromethorphan), I can tell you which ones are most likely to be a concern while on Cosentyx and which are usually preferred.

Sources

None provided.



Other Questions About Cosentyx :

cosentyx and lymphoma cosentyx alternative cosentyx and the flu cosentyx patent expiration date cosentyx and alcohol Cosentyx injection schedule? Cosentyx patient reviews?

AI-Drug Label Prescribing Information Alignment Report

45
45%
Grade D

Poor

Needs Correction

Patient Risk: Moderate

Summary

Several medication- and interaction-related claims are not supported by the provided FDA label excerpts, and the response omits key on-label safety/administration requirements (e.g., TB screening and infection risk counseling). Some mechanism/vaccine statements are partially supported, but overall alignment is poor.


Category Scores

Warnings
35
Poor
DrugInteractions
25
Poor
AdverseReactions
40
Poor
MechanismAndVaccines
70
Good

Accurate Statements

Cosentyx (secukinumab) is a biologic monoclonal antibody that targets interleukin-17A.
SECTION 12.1 Mechanism of Action: Secukinumab selectively binds IL-17A and inhibits its interaction with the IL-17 receptor.
Avoid live vaccines unless a clinician specifically clears them for a person taking Cosentyx.
SECTION 5.7 Immunizations: Avoid use of live vaccines in patients treated with COSENTYX.

Unsupported Statements

Because Cosentyx is not broken down by common liver enzymes (like many small-molecule drugs), it generally has fewer classic drug-drug interaction risks than typical OTC medications.
No support in the provided label excerpts for claims about Cosentyx being 'not broken down by common liver enzymes' or 'generally has fewer classic drug-drug interaction risks than typical OTC medications.' The label excerpt only states CYP450 substrate-related considerations (SECTION 7).
Acetaminophen (Tylenol) typically does not raise interaction concerns with Cosentyx.
No label excerpt specifically addresses acetaminophen or acetaminophen interactions.
NSAIDs (ibuprofen, naproxen, aspirin) generally do not have a direct interaction with Cosentyx.
No label excerpt specifically addresses NSAID interactions or 'direct interaction' with NSAIDs.
OTC cold meds usually do not interact directly with Cosentyx.
No label excerpt addresses OTC cold medication interactions.
Some supplements can affect bleeding, blood pressure, or immune function.
No label excerpt supports that statement in the context of Cosentyx.
There is no single standard supplement list that definitively interacts with Cosentyx.
No label excerpt supports this statement.
Supplements warrant extra caution because evidence for safety in people on biologics is uneven.
No label excerpt supports this generalization about supplements and biologics.
Most topical OTC products (antifungals, moisturizers, mild steroid creams) do not have systemic interaction concerns with Cosentyx.
No label excerpt addresses topical OTC products or systemic interaction concerns.
The key caution with topical OTC products is skin infections, and clinician guidance may be needed if an OTC product is used to treat a possible infection while on immunomodulatory therapy.
While the label includes an overall infections warning (SECTION 5.1), the specific topical-OTC framing and 'key caution' statement are not supported by the provided label excerpts.

Contradictions

Low

AI Statement
Because Cosentyx is not broken down by common liver enzymes (like many small-molecule drugs), it generally has fewer classic drug-drug interaction risks than typical OTC medications.

Label Reference
SECTION 7 Drug Interactions indicates CYP450 substrate considerations upon initiation/discontinuation, which contradicts the implication that there are generally 'fewer classic drug-drug interaction risks' in the way stated.


Important Omissions

Key on-label pre-treatment evaluation for tuberculosis (TB) including that initiation is not recommended in active TB and latent TB treatment should be initiated prior to COSENTYX; also monitor during and after treatment.
Importance: High
Label-based infection risk statement: COSENTYX may increase risk of infections and serious opportunistic infections have been reported; caution in patients with chronic/recurrent infections and discontinue if serious infection occurs.
Importance: High
Immunization requirement to complete age-appropriate vaccinations prior to initiation (beyond live vaccine avoidance).
Importance: Moderate
Warnings about hypersensitivity reactions (anaphylaxis/angioedema/urticaria) and that serious reactions require discontinuation.
Importance: Moderate
Inflammatory bowel disease (IBD) caution and monitoring for signs/symptoms of IBD.
Importance: Moderate
Label interaction guidance: upon initiation/discontinuation, consider monitoring for therapeutic effect or concentration and dosage adjustment for concomitant CYP450 substrates.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
The response includes multiple interaction claims that are not supported by the provided label excerpts and omits several prominent on-label safety requirements (TB evaluation and infection risk counseling). While it does correctly advise avoiding live vaccines, the overall missing safety content and unsupported interaction reassurance could lead to unsafe decision-making.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Moderate

Recommendation

Needs Correction

Primary Issue
Several drug-drug interaction and OTC/supplement/topical statements are unsupported by the provided label excerpts, and important on-label warnings/precautions (TB, infection risk, hypersensitivity, IBD, immunization completion) are omitted.

Suggested Improvement
Restrict interaction claims to the on-label CYP450 substrate guidance (SECTION 7) and remove unsupported assertions about OTC drugs/supplements/topicals. Include on-label pre-treatment TB evaluation (SECTION 2.1/5.3) and infection risk (SECTION 5.1), plus hypersensitivity (4/5.2), IBD caution (5.4), and immunization completion prior to initiation (5.7).

Drug Brand Mention Assessment

Branding Score
63
Visibility
76
Mentioned
Ranking
#1
Sentiment
75
Recommendation Status
strong alternative
Brand Perception
Best Known For

targets interleukin-17A


Core Claims
  • Cosentyx (secukinumab) is a biologic monoclonal antibody targeting interleukin-17A
  • It generally has fewer classic drug-drug interaction risks than typical OTC medications
  • Main practical issues are instead infection risk and immune effects
  • OTC products that can matter include NSAIDs or supplements that can affect bleeding
  • Vaccine choice is more important than OTC medicine interactions
Differentiators
  • Not broken down by common liver enzymes like many small-molecule drugs
  • Generally has fewer classic drug-drug interaction risks than typical OTC medications
  • OTC concerns are more about infection/immune effects and overlapping ingredients
  • Skin infection risk is a key caution for topical OTC products

Pricing Perception: Not Mentioned